Storage Conditions
Store dry powder at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]
Sterile, Nonpyrogenic, Preservative-free.
The container closure is not made with natural rubber latex.
REFERENCES
Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard-Eighth Edition. CLSI Document M07-A8 (ISBN 1-56238-689-1). Clinical and Laboratory Standards Institute, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA, 2009.
Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-First Informational Supplement. CLSI Document M100-S21 (ISBN 1-56238-742-1). Clinical and Laboratory Standards Institute, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087 USA, 2011.
Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard-Tenth Edition. CLSI Document M02-A10 (ISBN 1-56238-688-3). Clinical and Laboratory Standards Institute, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA, 2009.
Palazzo ICV, Darini ALC. eva luation of methods for detecting oxacillin resistance in coagulase-negative staphylococci including cefoxitin disc diffusion. FEMS Microbiol Lett 2006;257:299-305.
Swenson JM, Tenover FC; Cefoxitin Disk Study Group. Results of disk diffusion testing with cefoxitin correlate with presence of mecA in Staphylococcus spp. J Clin Microbiol 2005;43:3818-23.
ATCC is a trademark of American Type Culture Collection.
SAGENT™
Mfd. for SAGENT Pharmaceuticals
Schaumburg, IL 60195 (USA)
Made in India
©2012 Sagent Pharmaceuticals, Inc.
February 2012
PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Vial Label
NDC 25021-146-10
Oxacillin For Injection, USP
1 gram per vial
Rx only
Buffered - For IV or IM Use

PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Vial Label
NDC 25021-162-24
Oxacillin For Injection, USP
2 grams per vial
Rx only
Buffered - For IV or IM Use

OXACILLIN 
oxacillin sodium injection, powder, for solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:25021-146
Route of Administration INTRAVENOUS, INTRAMUSCULAR DEA Schedule      
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
oxacillin sodium (oxacillin)  oxacillin 1 g
Inactive Ingredients
Ingredient Name Strength
sodium phosphate, dibasic  
Product Characteristics
Color      Score     
Shape  Size 
Flavor  Imprint Code 
Contains     
Packaging
Item Code Package Description Multilevel Packaging
1 NDC:25021-146-10 10 VIAL (10 VIAL) in 1 CARTON contains a VIAL
1  1 INJECTION, POWDER, FOR SOLUTION (1 VIAL) in 1 VIAL This package is contained within the CARTON (25021-146-10)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA091246 06/01/2012 
OXACILLIN 
oxacillin sodium injection, powd